Aprogen Medicines Inc. (KRX:007460)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,030.00
+30.00 (1.50%)
Sep 11, 2026, 3:30 PM KST

Aprogen Medicines Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
37,89245,14837,16235,68443,07015,894
Short-Term Investments
-----4,000
Trading Asset Securities
5,2715,6126,5005,0004,390-
Cash & Short-Term Investments
43,16350,76043,66240,68447,46019,894
Cash Growth
-70.82%16.26%7.32%-14.28%138.57%-91.62%
Accounts Receivable
24,65425,97619,67424,80921,3891,567
Other Receivables
5,2383,5581,1701,6077,9889,759
Receivables
59,77160,61224,35634,63792,30656,990
Inventory
54,25360,89462,48360,81561,46723,257
Prepaid Expenses
-1,179967.42847.35913.48906.58
Other Current Assets
5,4855,1992,8497,2249,4322,052
Total Current Assets
162,672178,643134,317144,207211,578103,099
Property, Plant & Equipment
357,520367,267364,181362,959365,100314,479
Long-Term Investments
12,46719,2969,7902,4473,29854,786
Goodwill
50,95850,958----
Other Intangible Assets
10,90017,4156,1067,4898,4312,633
Long-Term Deferred Tax Assets
-2,683--662.84-
Long-Term Deferred Charges
56,19154,42046,60134,6254,988-
Other Long-Term Assets
21,88022,7883,9021,2245,2221,904
Total Assets
674,452717,265609,968594,428599,853477,646

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
7,0115,0143,4232,7344,1863,920
Accrued Expenses
4,4804,4452,6832,5564,1178,410
Short-Term Debt
29,103101,11435,78446,63149,763398,613
Current Portion of Long-Term Debt
114,70045,00045,00044,9387,675-
Current Portion of Leases
1,0001,030592.23560.08934.882,785
Current Income Taxes Payable
--246.72-4.18-
Current Unearned Revenue
825.88234.25----
Other Current Liabilities
37,77726,93225,23128,22223,2538,202
Total Current Liabilities
194,898183,769112,959125,64089,933421,929
Long-Term Debt
36,00040,00032,00032,00031,25131,046
Long-Term Leases
641.78718.46326.69288.35571.0319,925
Pension & Post-Retirement Benefits
13,45516,83515,69411,74010,3194,076
Long-Term Deferred Tax Liabilities
9,6838,7346,5905,3755,3221,167
Other Long-Term Liabilities
5,5298,5982,3081,6961,455309.39
Total Liabilities
260,206258,655169,878176,740138,851478,453

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
11,797164,653152,062132,419126,834260,351
Additional Paid-In Capital
532,378521,069512,886472,949431,64146,794
Retained Earnings
-381,817-488,200-418,506-358,604-293,691-192,837
Treasury Stock
-98,228-98,115-98,115-98,115-98,084-
Comprehensive Income & Other
-3,58658,90410,306-849.6748,392-112,146
Total Common Equity
60,544158,310158,634147,800215,0922,163
Minority Interest
353,702300,300281,457269,888245,910-2,970
Shareholders' Equity
414,246458,610440,091417,688461,002-806.44
Total Liabilities & Equity
674,452717,265609,968594,428599,853477,646

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
181,445187,862113,702124,41790,195452,369
Net Cash (Debt)
-138,282-137,102-70,041-83,732-42,736-432,475
Net Cash Growth
------
Net Cash Per Share
-6680.28-6913.76-4062.06-5318.10-3167.42-37416.92
Filing Date Shares Outstanding
21.620.5718.8916.2715.534.43
Total Common Shares Outstanding
21.620.5718.8916.2715.534.43
Working Capital
-32,226-5,12621,35718,567121,644-318,829
Book Value Per Share
2803.167696.278397.299083.1113851.34488.78
Tangible Book Value
-1,31489,938152,528140,311206,661-469.92
Tangible Book Value Per Share
-60.834372.338074.108622.8813308.41-106.18
Land
60,16160,08150,01244,13644,19012,484
Buildings
122,820122,711115,772115,622113,61188,041
Machinery
268,394268,124221,978195,122191,265137,051
Construction In Progress
29,20229,56661,140107,58088,23485,017